Cerebrovascular Disease

  • Melvina McCabe


Stroke is the third leading cause of death in the United States.1 The physical and emotional disability suffered after a stroke is significant, and the financial burden is tremendous. Direct costs, which include prevention, detection, and treatment for stroke, were estimated at $3.26 billion in 1976.2 For these reasons it is important for family physicians to know the risk factors for stroke that might predispose a patient, to implement a plan to prevent the development of the risk factors, to employ the most efficient method of evaluating someone with symptoms suggestive of a stroke, and to be aware of the management issues.


Subarachnoid Hemorrhage Intracerebral Hemorrhage Carotid Endarterectomy Cerebral Amyloid Angiopathy Posterior Circulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1..
    Monthly vital statistics report: births, marriages, divorces & deaths for 1989. Hyattsville, MD: US Dept. of Health, Education, and Welfare. Public Health Service, National Center for Health Statistics 1989;38(5):1–14.Google Scholar
  2. 2.
    Adelman SM. Economic impact. Natl Sury Stroke 1981;12 Suppl 1:169–78.Google Scholar
  3. 3.
    McDowell F, Caplan L. Cerebrovascular survey report 1985. Washington, DC: National Institutes of Health, 1985:1–209.Google Scholar
  4. 4.
    Robins M, Balm H. Incidence. Natl Sury Stroke 1981;12 Suppl 1:145–55.Google Scholar
  5. 5.
    Gallium R. Stroke in blacks. Stroke 1988;19(1):1–9.CrossRefGoogle Scholar
  6. 6.
    Wolf P, Kennel W, Verter I. Current status of risk factors for stroke. Neurol Clin 1983;1:317–43.PubMedGoogle Scholar
  7. 7.
    Kennel W, Wolf P, Verter J, McNamara R. Epidemiologic assessment of the role of blood pressure in stroke—the Framingham study. JAMA 1970;214:301–10.CrossRefGoogle Scholar
  8. 8.
    Balm H, Robins M. Survival and prevalence. Stroke 1981;12 Suppl 1:159–68.Google Scholar
  9. 9.
    Garraway WM, Whisnant JP, Furlan A, Phillips LH, Kurland LT, O’Fallon M. The declining incidence of stroke. N Engl J Med 1979;300:440–52.CrossRefGoogle Scholar
  10. 10.
    Broderick J, Phillips S, Whisnant J, O’Fallon WM, Bergstralh E. Incidence rates of stroke in the eighties: the end of the decline in stroke. Stroke 1989;20:577–82.PubMedCrossRefGoogle Scholar
  11. 11.
    Whisnant J. The decline of stroke. Stroke 1984;15:160–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Colandrea M, Friedman G, Nichaman M, Lynd C. Systolic hypertension in the elderly. Geriatrics 1970;41:239–45.Google Scholar
  13. 13.
    Garland C, Barret-Connor E, Suarez L, Criqui M. Isolated systolic hypertension and mortality after age 60 years. Am J Epidemiol 1983;118:365–76.PubMedGoogle Scholar
  14. 14.
    Kennel W, Wolf PA, McGee D, Dawber T, McNamara P, Castelli W. Systolic blood pressure, arterial rigidity and risk of stroke—the Framingham study. JAMA 1981;245:1225–9.CrossRefGoogle Scholar
  15. 15.
    Hulley S, Furberg CD, Gurland B, et al. Systolic hypertension in the elderly program (SHEP): antihypertensive efficacy of chlorthalidone. Am J Cardiol 1985;56:913–20.PubMedCrossRefGoogle Scholar
  16. 16.
    Whisnant J. Epidemiology of stroke: emphasis on transient cerebral ischemic attacks and hypertension. Stroke 1974;5: 68–70.PubMedCrossRefGoogle Scholar
  17. 17.
    Dyken M, Wolf P, Bamett HJM, et al. Risk factors in stroke. Stroke 1984;15:1105–11.CrossRefGoogle Scholar
  18. 18.
    Thompson P, Robinson J. Stroke after acute myocardial infarction: relation to infarct size. BMJ 1978;2:457–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Wolf P, Dawber T, Thomas E, Kennel W. Epidemiologic assessment of chronic artrial fibrillation and risk of stroke: the Framingham study. Neurology 1978;28:973–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Millikan C, McDowell F, Easton JD. Stroke. Philadelphia: Lea & Febiger, 1987.Google Scholar
  21. 21.
    Kannel W, Gordon T, Wolf P, McNamara R. Hemoglobin and the risk of cerebral infarction: the Framingham study. Stroke 1972;3:409–19.PubMedCrossRefGoogle Scholar
  22. 22.
    Stampfer M, Colditz G, Willett W, Speizer F, Hennekens C. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988;319(5):267–73.PubMedCrossRefGoogle Scholar
  23. 23.
    Jaswinder G, Zezulka A, Shipley M, Gill S, Beevers DG. Stroke and alcohol consumption. N Engl J Med 1986;315(17): 1041–6.CrossRefGoogle Scholar
  24. 24.
    Wolf P, D’Agostino R, Kannel W, Bonita R, Belanger A. Cigarette smoking as a risk factor for stroke—the Framingham study. JAMA 1988;259(7):1025–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Stehbens WE. Pathology of cerebral blood vessels. St. Louis: Mosby, 1972:189–91.Google Scholar
  26. 26.
    Hennerici M, Hulsbomer HB, Rautenberg W, Hefter H. Spontaneous history of asymptomatic internal carotid occlusion. Stroke 1986;17:718–22.PubMedCrossRefGoogle Scholar
  27. 27.
    Fischer CM, Gore I, Okabe N, White PD. Atherosclerosis of the carotid and vertebral arteries—extracranial and infracranial. In: Proceedings of the American Association of Neuropathologists. Atlantic City, NJ: AAN, 1962:455–76.Google Scholar
  28. 28.
    Hennerici M, Albrecht A, Sandmann W, Freund HJ. Incidence of asymptomatic extracranial arterial disease. Stroke 1981;12:750–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Asinger R, Dyken M, Fisher M, Hart RG, Sherman DG. Cardiogenic brain embolism: the second report of the Cerebral Embolism Task Force. Arch Neurol 1989;46:727–43.CrossRefGoogle Scholar
  30. 30.
    Barnett HJM. Heart in ischemic stroke—a changing emphasis. Neurol Clin 1983;1:291–314.PubMedGoogle Scholar
  31. 31.
    Calandre L, Gomara S, Bermejo F, Millan J, Del Pozo G. Clinical CT correlations in TIA, RIND, and strokes with minimum residuum. Stroke 1984;15:663–5.PubMedCrossRefGoogle Scholar
  32. 32.
    Fisher M. Occlusion of the internal carotid artery. AMA Arch Neurol Psychiatry 1951;65:346–77.PubMedCrossRefGoogle Scholar
  33. 33.
    Stehbens WE. Thrombosis, embolism, infarction, and vascular insufficiency. In: Pathology of the cerebral vessels. St. Louis: Mosby, 1972:131–200.Google Scholar
  34. 34.
    Hacke W, Hennerici M, Gelmers HJ, Kramer G. Cerebral ischemia. New York: Springer-Verlag, 1991.CrossRefGoogle Scholar
  35. 35.
    Cole FM, Yates PO. The occurrence and significance of intracerebral micro-aneurysms. J Pathol Bacteriol 1967;93:393411.Google Scholar
  36. 36.
    Wolf P, Kannel W, Verter J. Current status of risk factors for stroke. Neurol Clin 1983;1:317–43.PubMedGoogle Scholar
  37. 37.
    McCormick W, Rosenfield D. Massive brain hemorrhage: a review of 144 cases and an examination of their causes. Stroke 1973;4:946–54.PubMedCrossRefGoogle Scholar
  38. 38.
    Furlan A, Whisnant J, Elveback L. The decreasing incidence of primary intracerebral hemorrhage: a population study. Ann Neurol 1979;5:367–73.PubMedCrossRefGoogle Scholar
  39. 39.
    Vinters H, Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. 11. The distribution of amyloid vascular changes. Stroke 1983;14:924–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Wolf P, Kannel W, Verter J. Current status of risk factors for stroke. Neurol Clin 1983;1:317–43.PubMedGoogle Scholar
  41. 41.
    Sahs A, Perret G, Locksley H, Nishioka H. Intracranial aneurysms and subarachnoid hemorrhage. Philadelphia: Lippincott, 1969.Google Scholar
  42. 42.
    Okawara SH. Warning signs prior to rupture of an intracranial aneurysm. J Neurosurg 1973;38:575–80.PubMedCrossRefGoogle Scholar
  43. 43.
    Roach ES, Garcia JC, McLean W. Cerebrovascular disease in children. Am Fam Physician 1984;30:215–25.PubMedGoogle Scholar
  44. 44.
    Solomon G. Strokes in children. Pediatr Neurol 1978;7: 813–25.Google Scholar
  45. 45.
    Golden G. Strokes in children and adolescents. Stroke 1977; 9:169–71.CrossRefGoogle Scholar
  46. 46.
    Matson D. Intracranial arterial aneurysms in childhood. J Neurosurg 1965;23:578–83.PubMedCrossRefGoogle Scholar
  47. 47.
    Heyman A. Risk of stroke in asymptomatic persons with cervical arterial bruits. N Engl J Med 1980;4:838–41.CrossRefGoogle Scholar
  48. 48.
    Norris J, Hachinski V. Prevention of stroke. New York: Springer-Verlag, 1991.CrossRefGoogle Scholar
  49. 49.
    Chambers BR, Norris JW. Clinical significance of asymptomatic neck bruits. Neurology 1985;35:742–5.PubMedCrossRefGoogle Scholar
  50. 50.
    Ingall T, Homer D, Whisnant J, Baker HL, O’Fallon WM. Predictive value of carotid bruit for carotid atherosclerosis. Arch Neurol 1989;46:418–422.PubMedCrossRefGoogle Scholar
  51. 51.
    Howard V. Correlation of carotid bruits and carotid atherosclerosis detected by B-mode real-time ultrasonography. Stroke 1989;20:1331–5.PubMedCrossRefGoogle Scholar
  52. 52.
    Ruff R, Dougherty J. Evaluation of acute cerebral ischemia for anticoagulant therapy: computed tomography or lumbar puncture. Neurology 1981;31:736–40.PubMedCrossRefGoogle Scholar
  53. 53.
    Kertesz A, Black S, Nicholson L, Carr T. The sensitivity and specificity of MRI in stroke. Neurology 1987;37:1580–5.PubMedCrossRefGoogle Scholar
  54. 54.
    Ramadan N, Deveshwar R, Levine S. Magnetic resonance and clinical cerebrovascular disease. Stroke 1989;20:1279–83.PubMedCrossRefGoogle Scholar
  55. 55.
    Fisher M, Bogousslaysky J. Evolving toward effective therapy for acute ischemic stroke. JAMA 1993;270:360–4.PubMedCrossRefGoogle Scholar
  56. 56.
    DeRook F, Comess K, Albers G, Popp R. Transesophageal echocardiography in the evaluation of stroke. Ann Intern Med 1992;117:922–32.PubMedCrossRefGoogle Scholar
  57. 57.
    Silver F, Norris JW, Lewis A, Hachinski V. Early mortality following stroke: a prospective review. Stroke 1984;15:492–6.PubMedCrossRefGoogle Scholar
  58. 58.
    Brott T, Reed RL. Intensive care for acute stroke in the community hospital setting: the first 24 hours. Stroke 1989;20: 694–7.PubMedCrossRefGoogle Scholar
  59. 59.
    Biller J, Asconape JJ, Barton JS, et al. Poststroke seizures in the elderly. Clin Geriatr Med 1991;7:483–92.Google Scholar
  60. 60.
    Bayer A, Pathy MSJ, Newcombe R. Double blind randomised trial of intravenous glycerol in acute stroke. Lancet 1987;1:405–7.PubMedCrossRefGoogle Scholar
  61. 61.
    Weksler B, Lewin M. Anticoagulation in cerebral ischemia. Stroke 1983;14:658–63.PubMedCrossRefGoogle Scholar
  62. 62.
    Scheinberg R. Heparin anticoagulation. Stroke 1989;20: 173–4.PubMedCrossRefGoogle Scholar
  63. 63.
    Yatsu F, Hart R, Mohr J, Grotta J. Anticoagulation of embolic strokes of cardiac origin: an update. Neurology 1988; 38:314–16.PubMedCrossRefGoogle Scholar
  64. 64.
    Laupacis A, Albers G, Dunn M, Feinberg W. Antithrombotic therapy in atrial fibrillation. Chest 1992;102:426s–33s.PubMedCrossRefGoogle Scholar
  65. 65.
    Stein P, Alpert J, Copeland J, Dalen J, Goldman S, Turpie AGG. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1992;102:445s–555.PubMedCrossRefGoogle Scholar
  66. 66.
    Acheson J, Archibald D, Barnett H, et al. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 1988;296:320–31.CrossRefGoogle Scholar
  67. 67.
    Gent M, Blakely JA, Easton JD, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989;1:1215–20.PubMedCrossRefGoogle Scholar
  68. 68.
    Hass W, Easton JD, Adams HP, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989;321:501–7.PubMedCrossRefGoogle Scholar
  69. 69.
    North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med 1991;325:445–53.CrossRefGoogle Scholar
  70. 70.
    European Carotid Surgery Trialists’ Collaborative Group. MRC European carotid surgery trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet 1991;337:1235–43.CrossRefGoogle Scholar
  71. 71.
    European Carotid Surgery Trialists Collaborative Group. Risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 1995;345:209–12.CrossRefGoogle Scholar
  72. 72.
    Roederer GO, Langlois YE, Jager KA, et al. The natural history of carotid arterial disease in asymptomatic patients with cervical bruits. Stroke 1984;15:605–13.PubMedCrossRefGoogle Scholar
  73. 73.
    Higashida RT. Interventional neurovascular techniques for cerebral revascularization in the treatment of stroke. AJR 1994;163:793–800.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Melvina McCabe

There are no affiliations available

Personalised recommendations